5Metis Revenue and Competitors
Employee Data
- 5Metis has 16 Employees.
- 5Metis grew their employee count by -6% last year.
5Metis's People
Name | Title | Email/Phone |
---|
5Metis Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $11.2M | 63 | 7% | N/A | N/A |
#2 | $5099.8M | 32902 | -4% | N/A | N/A |
#3 | $1.7M | 11 | 0% | N/A | N/A |
#4 | $0.6M | 4 | -56% | N/A | N/A |
#5 | N/A | 15 | 7% | N/A | N/A |
#6 | $0.9M | 11 | -39% | N/A | N/A |
#7 | $1.7M | 9 | 0% | N/A | N/A |
#8 | $0.6M | 3 | 0% | N/A | N/A |
#9 | $4.8M | 31 | -6% | N/A | N/A |
#10 | $6.4M | 36 | 6% | N/A | N/A |
What Is 5Metis?
Welcome to 5Metis, Inc. 5Metis is a novel mode of action and intellectual property development company solving fungicide resistance for growers worldwide. Headquartered in Research Triangle Park, North Carolina, 5Metis was founded in 2021. Since its founding, 5Metis has discovered and validated multiple novel modes of action for agricultural fungicides.\n\nToday, 5Metis leverages its natural product screening and boron chemistry (NAB) platform to deliver novel modes of action not currently found in the agrichemical industry. As a result, 5Metis compounds break resistance to existing fungicides and can reduce application rates substantially. 5Metis is the only company with this unique intellectual property, exclusive boron chemistry library, and overall know-how to drive truly differentiated solutions.\n\nThe 5Metis business model focuses on discovery and early development and collaborates with channel partners for further development of de‐risked compounds with attractive biological profiles.\n \n\n \n \n Show more\n \n\n \n\n\n \n \n Show less
keywords:N/AN/A
Total Funding
16
Number of Employees
N/A
Revenue (est)
-6%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $2.9M | 16 | -20% | N/A |
#2 | N/A | 16 | 33% | N/A |
#3 | $1.2M | 16 | -24% | $7.5M |
#4 | N/A | 16 | 60% | N/A |
#5 | $1M | 16 | 45% | N/A |